中文产业新闻评分28Chinese source
Genentech的RGT-419B（CDK2/CDK4抑制剂）启动HR+/HER2-乳腺癌Ib期临床试验
10月魔方TOP药企动态播报 | Genentech-RGT-419B启动一项 针对乳腺癌的Phase I临床试验
No English body on site. Use the original article link above, or open the Chinese edition for the editorial note.